Review



antibacterial activity against e coli atcc 25922  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC antibacterial activity against e coli atcc 25922
    Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of <t>E.</t> <t>coli</t> , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).
    Antibacterial Activity Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 49383 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibacterial activity against e coli atcc 25922/product/ATCC
    Average 99 stars, based on 49383 article reviews
    antibacterial activity against e coli atcc 25922 - by Bioz Stars, 2026-06
    99/100 stars

    Images

    1) Product Images from "A next-generation probiotic strain for gut health: Bacteroides cellulosilyticus LYH2 variant with anti-inflammatory and metabolic advantages"

    Article Title: A next-generation probiotic strain for gut health: Bacteroides cellulosilyticus LYH2 variant with anti-inflammatory and metabolic advantages

    Journal: eBioMedicine

    doi: 10.1016/j.ebiom.2026.106232

    Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of E. coli , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).
    Figure Legend Snippet: Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of E. coli , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).

    Techniques Used: Bacteria, Cell Culture, Two Tailed Test, Control, Comparison, Co-Culture Assay, Evaporation



    Similar Products

    99
    ATCC antibacterial activity against e coli atcc 25922
    Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of <t>E.</t> <t>coli</t> , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).
    Antibacterial Activity Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibacterial activity against e coli atcc 25922/product/ATCC
    Average 99 stars, based on 1 article reviews
    antibacterial activity against e coli atcc 25922 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC significant antibacterial activity against e coli atcc 25922
    Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of <t>E.</t> <t>coli</t> , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).
    Significant Antibacterial Activity Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/significant antibacterial activity against e coli atcc 25922/product/ATCC
    Average 99 stars, based on 1 article reviews
    significant antibacterial activity against e coli atcc 25922 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC antibacterial activity against e coli atcc 25922 lux
    Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of <t>E.</t> <t>coli</t> , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).
    Antibacterial Activity Against E Coli Atcc 25922 Lux, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibacterial activity against e coli atcc 25922 lux/product/ATCC
    Average 99 stars, based on 1 article reviews
    antibacterial activity against e coli atcc 25922 lux - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC antibacterial activity against e coli atcc
    Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of <t>E.</t> <t>coli</t> , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).
    Antibacterial Activity Against E Coli Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibacterial activity against e coli atcc/product/ATCC
    Average 99 stars, based on 1 article reviews
    antibacterial activity against e coli atcc - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    95
    ATCC antibacterial activity against e coli 412 atcc 25922
    Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of <t>E.</t> <t>coli</t> , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).
    Antibacterial Activity Against E Coli 412 Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibacterial activity against e coli 412 atcc 25922/product/ATCC
    Average 95 stars, based on 1 article reviews
    antibacterial activity against e coli 412 atcc 25922 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    99
    ATCC weak antibacterial activity against e coli atcc 25922
    Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of <t>E.</t> <t>coli</t> , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).
    Weak Antibacterial Activity Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/weak antibacterial activity against e coli atcc 25922/product/ATCC
    Average 99 stars, based on 1 article reviews
    weak antibacterial activity against e coli atcc 25922 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    Image Search Results


    Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of E. coli , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).

    Journal: eBioMedicine

    Article Title: A next-generation probiotic strain for gut health: Bacteroides cellulosilyticus LYH2 variant with anti-inflammatory and metabolic advantages

    doi: 10.1016/j.ebiom.2026.106232

    Figure Lengend Snippet: Metabolite profile of B. cellulosilyticus LYH2 and demonstration of the antimicrobial potential of its metabolites in co-cultivation with pathogenic bacteria. (A) Production of SCFAs by B. cellulosilyticus LYH2 cultured in BHI medium. Quantified SCFAs include AA, PA, BA, IBA, VA, and IVA. Data are presented as mean ± SEM. Asterisks denote statistical significance (∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001) as determined by unpaired two-tailed Student's t -test (∗ P < 0.05). Isovalerate was detected exclusively in the B. cellulosilyticus LYH2 group and was below the limit of detection in the BHI control. Therefore, no statistical comparison was applicable. (B–C) The volcano plots visually represent the magnitude fold change (|log2FC| > 1) and statistical significance (FDR < 0.05) of metabolites in positive and negative ion modes, contrasting their abundance in Ce and BHI media (n = 3). (D–E) The Principal Component Analysis (PCA) plots depict the clustering of samples based on positive and negative ion mode metabolite profiles in BHI and Ce media. Distinct colours represent separate groups. (F) A bar plot presents the enrichment of KEGG pathways, comparing the metabolic differences between Ce and BHI media (n = 3). (G) The preparation and subsequent co-culture process of B. cellulosilyticus LYH2 metabolites. (i) Metabolite solids are obtained via nitrogen evaporation under high-purity nitrogen conditions. (ii) Comparison of bacterial culture concentrations before and after the addition of B. cellulosilyticus LYH2 metabolites. The tubes on the left and right serve as positive controls containing pathogens, while the middle tubes represent the metabolite treatment group. (H–J) Growth curves of E. coli , S. aureus , and S. T yphimurium with and without the addition of metabolites (n = 3).

    Article Snippet: Antibacterial activity against E. coli ATCC 25922, S. aureus ATCC 25923, and S. T yphimurium ATCC 14028 was assessed by co-culturing, with detailed methods provided in the .

    Techniques: Bacteria, Cell Culture, Two Tailed Test, Control, Comparison, Co-Culture Assay, Evaporation